GenLumina
Treating Cancer With Light
Our “Silver Bullet” approach offers cancer treatments that attack and kill cancer cells, reducing damage to healthy tissue. This results in fewer side effects, faster recovery, and greater hope for long-term remission.
Grants & Loans Secured
Research Projects in Progress
Cancer Indications Targeted
We believe in a world where cancer treatment is not a luxury, but a right. Our mission is to close the gap in global cancer care by offering safe, effective, and synergistic treatments to patients everywhere.
Why GenLumina?
Drug Design
We use DNA-encapsulated silver nanoclusters to create a drug small enough to enter tumor cell nuclei.
Activation Mechanism
Once inside the tumor cell nucleus, the drug is activated by light, triggering a controlled toxic spike that directly attacks the cancer cell, leaving healthy tissues unharmed.
Safety and Efficacy
Our approach is less invasive, easing the burden on patients and healthcare systems.
Reduced Side Effects
Genlumina’s approach minimizes harm to healthy tissues, leading to fewer side effects and quicker recovery times for patients.
Integration and Scalability
Starting with skin cancer, our platform can expand to treat a wide range of cancers .
Learn more
Explore Our Technology
GenLumina’s innovation lies in our light-activated DNA nanotechnology. We create ultra-small packages to deliver a toxic payload directly into the cell nucleus. Using Two-Photon excitation, Spatial Light Modulation, and light-compatible needles, we activate the drug precisely at the tumor site.
Controlled and localised destruction
Treating cancer cells with unmatched accuracy, limiting side effects.
Compatibility with Existing Equipment
Scalable solutions using widely available surgical equipment in operating rooms.
Our technology doesn’t just treat cancer;
it’s designed to reshape we manage cancer globally.